7:46 PM
Feb 06, 2019
 |  BC Extra  |  Company News

Immuno-neurology company Alector dips after $175.8M IPO

Editor's Note: This article was updated on Feb 07, 2019 at 4:05 PM PST

Alector Inc. (NASDAQ:ALEC) shares fell $1 to $18 Thursday after the company raised $175.8 million in an IPO to support clinical trials of a handful of antibodies for neurologic indications including frontotemporal dementia and Alzheimer's disease.

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >